• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒/端粒酶系统损伤在早期慢性淋巴细胞白血病中的相关性

Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.

作者信息

Hoxha Mirjam, Fabris Sonia, Agnelli Luca, Bollati Valentina, Cutrona Giovanna, Matis Serena, Recchia Anna Grazia, Gentile Massimo, Cortelezzi Agostino, Morabito Fortunato, Bertazzi Pier Alberto, Ferrarini Manlio, Neri Antonino

机构信息

Department of Clinical Sciences and Community Health, Center of Molecular and Genetic Epidemiology, University of Milan, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

出版信息

Genes Chromosomes Cancer. 2014 Jul;53(7):612-21. doi: 10.1002/gcc.22171. Epub 2014 Apr 4.

DOI:10.1002/gcc.22171
PMID:24706380
Abstract

Several studies have proposed telomere length and telomerase activity as prognostic factors in chronic lymphocytic leukemia (CLL), whereas information addressing the role of telomere-associated genes is limited. We measured relative telomere length (RTL) and TERT expression levels in purified peripheral CD19(+) B-cells from seven healthy donors and 77 untreated CLLs in early stage disease (Binet A). Data were correlated with the major biological and cytogenetic markers, global DNA methylation (Alu and LINE-1), and clinical outcome. The expression profiles of telomere-associated genes were also investigated. RTL was decreased in CLLs as compared with controls (P < 0.001); within CLL, a progressive and significant RTL shortening was observed in patients from 13q- through +12, 11q-, and 17p- alterations; short telomeres were significantly associated with unmutated IGHV configuration and global DNA hypomethylation. Decreased RTL was associated with a shorter time to first treatment. A significant upregulation of POT1, TRF1, RAP1, MRE11A, RAD50, and RPA1 transcript levels was observed in CLLs compared with controls. Our study suggests that impairment of telomere/telomerase system represents an early event in CLL pathogenesis. Moreover, the correlation between telomere shortening and global DNA hypomethylation supports the involvement of DNA hypomethylation to increase chromosome instability. © 2014 Wiley Periodicals, Inc.

摘要

多项研究提出端粒长度和端粒酶活性可作为慢性淋巴细胞白血病(CLL)的预后因素,而关于端粒相关基因作用的信息有限。我们检测了来自7名健康供者和77例疾病早期(Binet A期)未经治疗的CLL患者纯化外周血CD19(+) B细胞中的相对端粒长度(RTL)和TERT表达水平。数据与主要生物学和细胞遗传学标志物、整体DNA甲基化(Alu和LINE-1)以及临床结局相关。我们还研究了端粒相关基因的表达谱。与对照组相比,CLL患者的RTL降低(P < 0.001);在CLL患者中,从13q-到 +12、11q-和17p-改变的患者观察到RTL呈进行性且显著缩短;短端粒与未突变的IGHV构型和整体DNA低甲基化显著相关。RTL降低与首次治疗时间缩短相关。与对照组相比,CLL患者中POT1、TRF1、RAP1、MRE11A、RAD50和RPA1转录水平显著上调。我们的研究表明,端粒/端粒酶系统受损是CLL发病机制中的早期事件。此外,端粒缩短与整体DNA低甲基化之间的相关性支持DNA低甲基化参与增加染色体不稳定性。© 2014威利期刊公司

相似文献

1
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.端粒/端粒酶系统损伤在早期慢性淋巴细胞白血病中的相关性
Genes Chromosomes Cancer. 2014 Jul;53(7):612-21. doi: 10.1002/gcc.22171. Epub 2014 Apr 4.
2
Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.端粒长度和端粒酶活性可预测B细胞慢性淋巴细胞白血病患者的生存期。
Cancer Res. 1998 Nov 1;58(21):4918-22.
3
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.端粒长度和端粒酶水平可区分具有不同生物学特征和临床结局的 B 细胞慢性淋巴细胞白血病亚群。
Haematologica. 2012 Jan;97(1):56-63. doi: 10.3324/haematol.2011.049874. Epub 2011 Sep 20.
4
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.端粒维持基因表达的变化提示B细胞慢性淋巴细胞白血病中存在整体端粒功能障碍。
Blood. 2008 Feb 15;111(4):2388-91. doi: 10.1182/blood-2007-09-111245. Epub 2007 Dec 12.
5
[Telomere length and telomerase expression activity in mononuclear cells of patients with chronic lymphocytic leukemia].[慢性淋巴细胞白血病患者单核细胞中的端粒长度及端粒酶表达活性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1409-12.
6
Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.端粒长度和人类端粒酶逆转录酶剪接变异体在慢性淋巴细胞白血病中的表达。
Exp Hematol. 2013 Jul;41(7):615-26. doi: 10.1016/j.exphem.2013.03.008. Epub 2013 Mar 30.
7
Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.端粒缩短与慢性淋巴细胞白血病中基因组复杂性增加相关。
Tumour Biol. 2015 Nov;36(11):8317-24. doi: 10.1007/s13277-015-3556-2. Epub 2015 May 26.
8
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.急性和慢性白血病在体外培养前后的端粒酶活性和端粒长度
Cancer Res. 2000 Feb 1;60(3):610-7.
9
Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia.SUV39H1和SUV39H2甲基转移酶水平异常与慢性淋巴细胞白血病的基因组不稳定有关。
Environ Mol Mutagen. 2017 Dec;58(9):654-661. doi: 10.1002/em.22128. Epub 2017 Aug 19.
10
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.端粒功能障碍和融合在慢性淋巴细胞白血病进展过程中的作用:端粒危机的证据。
Blood. 2010 Sep 16;116(11):1899-907. doi: 10.1182/blood-2010-02-272104. Epub 2010 Jun 10.

引用本文的文献

1
The Telomere Length Signature in Leukemias-From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase.白血病中的端粒长度特征——从端粒缩短的分子机制到针对端粒酶的免疫治疗选择
Cancers (Basel). 2025 Jun 10;17(12):1936. doi: 10.3390/cancers17121936.
2
Beyond Telomeres: Unveiling the Extratelomeric Functions of TERT in B-Cell Malignancies.超越端粒:揭示端粒酶逆转录酶在B细胞恶性肿瘤中的端粒外功能
Cancers (Basel). 2025 Mar 30;17(7):1165. doi: 10.3390/cancers17071165.
3
Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancer.
MRE11在DNA损伤修复途径动态变化中的作用及其在遗传性乳腺癌和卵巢癌中的诊断和预后意义。
BMC Cancer. 2025 Apr 9;25(1):650. doi: 10.1186/s12885-025-14082-3.
4
Deletion of 17p in cancers: Guilt by (p53) association.癌症中17号染色体短臂缺失:因(p53)关联而获罪。
Oncogene. 2025 Mar;44(10):637-651. doi: 10.1038/s41388-025-03300-8. Epub 2025 Feb 18.
5
Combatting cellular immortality in cancers by targeting the shelterin protein complex.通过靶向庇护蛋白复合物来对抗癌症中的细胞不朽性。
Biol Direct. 2024 Nov 22;19(1):120. doi: 10.1186/s13062-024-00552-4.
6
Genetically predicted telomere length and the risk of 11 hematological diseases: a Mendelian randomization study.基于遗传预测的端粒长度与 11 种血液系统疾病风险的关联:一项孟德尔随机化研究。
Aging (Albany NY). 2024 Feb 22;16(5):4270-4281. doi: 10.18632/aging.205583.
7
RAP1/TERF2IP-A Multifunctional Player in Cancer Development.RAP1/TERF2IP——癌症发展中的多功能参与者
Cancers (Basel). 2021 Nov 27;13(23):5970. doi: 10.3390/cancers13235970.
8
Mechanism of Human Telomerase Reverse Transcriptase () Regulation and Clinical Impacts in Leukemia.人类端粒酶逆转录酶()的调节机制及其在白血病中的临床影响。
Genes (Basel). 2021 Jul 30;12(8):1188. doi: 10.3390/genes12081188.
9
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia.淋巴细胞倍增时间作为预测早期慢性淋巴细胞白血病首次治疗时间的关键预后因素
Front Oncol. 2021 Aug 2;11:684621. doi: 10.3389/fonc.2021.684621. eCollection 2021.
10
Non-canonical roles of canonical telomere binding proteins in cancers.非典型端粒结合蛋白在癌症中的作用。
Cell Mol Life Sci. 2021 May;78(9):4235-4257. doi: 10.1007/s00018-021-03783-0. Epub 2021 Feb 18.